WO2001074983A1 - Foamable antimicrobial formulation - Google Patents
Foamable antimicrobial formulation Download PDFInfo
- Publication number
- WO2001074983A1 WO2001074983A1 PCT/US2001/009267 US0109267W WO0174983A1 WO 2001074983 A1 WO2001074983 A1 WO 2001074983A1 US 0109267 W US0109267 W US 0109267W WO 0174983 A1 WO0174983 A1 WO 0174983A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formulation
- antimicrobial
- weight
- centipoise
- ammonium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0094—High foaming compositions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/16—Foams
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
- A01N31/16—Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/055—Phenols the aromatic ring being substituted by halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/37—Mixtures of compounds all of which are anionic
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/83—Mixtures of non-ionic with anionic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2003—Alcohols; Phenols
- C11D3/2006—Monohydric alcohols
- C11D3/2034—Monohydric alcohols aromatic
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2068—Ethers
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/24—Organic compounds containing halogen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/123—Sulfonic acids or sulfuric acid esters; Salts thereof derived from carboxylic acids, e.g. sulfosuccinates
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/126—Acylisethionates
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/29—Sulfates of polyoxyalkylene ethers
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/72—Ethers of polyoxyalkylene glycols
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/722—Ethers of polyoxyalkylene glycols having mixed oxyalkylene groups; Polyalkoxylated fatty alcohols or polyalkoxylated alkylaryl alcohols with mixed oxyalkylele groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- This invention relates to antimicrobial formulations. More particularly, the invention relates to formulations that may be utilized in dispensing devices that generate a foam. Such formulations are particularly useful in the health care profession such as in surgical practice as a pre-operative scrub. Hand washing by healthcare professionals is an essential component of infection control activities. Healthcare professionals wash their hands regularly to control the spread of infection from patient to patient. Hand washing procedures are performed in several ways and include products such as ordinary antimicrobial bar soaps, skin disinfecting or pre-operative prepping agents or rubbing alcohol. Such procedures and products may contain antimicrobial agents such as iodine, chlorhexidine gluconate, para-chlorometa-xylenol and hexachlorophenes.
- Some solution dispensing systems provide a means for foaming the antimicrobial solution so that the solution is dispensed in a foamed state.
- An example of a foam solution dispensing system is described in copending United States patent application serial number 09/512,402, entitled, "Foam Forming Liquid Dispensing Device.”
- the foam generating device and system disclosed in United States application serial number 09/512,402 dispenses a homogeneous foam solution when the proper mixing of foamable solution and air occurs.
- the system includes a pressure generating source, such as a foot pump, which creates an increased pressure inside the closed container. This positive pressure difference across the container wall results in the solution being forced up the solution delivery straw. This increased pressure also forces air into the solution delivery straw via the air delivery cross tube located above the level of the foamable solution. The air/solution mixture is then allowed to expand downstream of the air delivery cross tube prior to be forced through a flow restricter, which further homogenizes the air/solution mixture.
- the solutions used in dispensing devices are high viscosity, which require higher pressure to force the solution up the solution delivery straw.
- the increased pressure needed to deliver the solution tends to deliver too much air into the system, which can cause in an improper ratio of solution to air, and ultimately a poorly foamed solution.
- Higher viscosity solutions also do not expand and mix as readily when being forced around and through the flow restricters in the dispensing devices.
- the solution described in United States patent number 5,439,681 which has a viscosity in the range of 490 to 500 centipoise at 24° C, is difficult to deliver through foaming dispenser devices that include flow restricters.
- a low viscosity, highly foamable solution is therefore needed to provide the desirable foam output characteristics while maintaining other desirable characteristics. Accordingly, it would be desirable to provide an antimicrobial formulation having a low viscosity, which is highly foamable when used in a foam dispensing device. Additionally, it would be advantageous if the foam produced from the solution is homogenous, consisting of small, homogenous bubbles, having consistency that is neither too wet nor too dry. It would also be desirable it the foam could be smoothly delivered at a consistent volume through the delivery device.
- the present invention is an aqueous foamable antimicrobial formulation comprising an antimicrobial agent, surfactants and emollients.
- the formulation may be effectively used as a surgical scrub without irritation or dryness to skin.
- the aqueous foamable, antimicrobial cleansing formulation of the present invention comprises about 1 % to about 4% of an antimicrobial agent having a phenol moeity, about 18% to about surfactants, anionic surfactants, amphoteric surfactants, and mixtures thereof; and about 1 % to about 5% of an emollient.
- formulation has a viscosity less than 300 centipoise at 24° C, and the viscosity is more preferably less than 200 centipoise at 24° C.
- the formulation has a viscosity less than 100 centipoise at 24° C, typically in the range of about 5 centipoise to about 30 centipoise at 24° C.
- the antimicrobial agent used in the formulation includes triclosan or para-chlorometa-xylenol.
- the surfactant used in the formulation includes an ammonium salt of sulfated nonylphenoxypolyethyloxyethanol, block copolymers of polyoxyethylene and polyoxypropylene, ammonium fatty sulfosuccinates, acyl isethionates and combinations thereof.
- the emollient is selected from lanolin, lanolin derivatives and aloe vera gel, and the formulation includes a glycol such as propylene glycol.
- the formulation comprises about 0.5% to about 4% para- chlorometa-xylenol or triclosan; about 5-20% ammonium cocoyl isethionate; about 1 % to about 7% block copolymers of polyoxypropylene and polyoxyethylene; about 3% to about 12% nonylphenoxypolyethylenoxy propanol; and about 2% to about 10% ammonium lauryl sulfosuccinate. The percentages are all in weight percent.
- the present invention provides an aqueous antimicrobial formulation that has lower viscosity than prior art antimicrobial formulations.
- the lower viscosity formulation of the present invention permits antimicrobial dispensing devices such as the device described in United States patent application serial number 09/512,402 to dispense a foam having small, homogenous bubbles at a consistent delivery volume.
- the solution provides consistent foam delivery when dispensed from such a dispensing device.
- the foam produced by the dispensing device has acceptable foam density and is delivered smoothly from the dispensing device.
- the present invention relates to aqueous foamable, antimicrobial formulations.
- One important feature of the formulations of the present invention is the formulations possess a viscosity less than about 300 centipoise at 24° C, preferably less than about 200 centipoise at 24° C, and most preferably less than about 100 centipoise at 24° C. It will be appreciated that the measured viscosity of the formulation will increase as the temperature of the formulation is lowered.
- the low viscosity solution of the present invention is particularly useful in foam generating dispensing devices, such as the type disclosed in copending United States patent application serial number 09/ 512,402.
- the aqueous, antimicrobial formulation of the present invention generally comprises about 0.5% to about 4% by weight of an antimicrobial agent having a phenol moeity, about 18% to about 35% by weight of a surfactant selected from the group consisting of nonionic surfactants, anionic surfactants, amphoteric surfactants, and mixtures thereof, and about 1 % to about 5% by weight of an emollient.
- an antimicrobial agent having a phenol moeity
- a surfactant selected from the group consisting of nonionic surfactants, anionic surfactants, amphoteric surfactants, and mixtures thereof, and about 1 % to about 5% by weight of an emollient.
- An antimicrobial agent is a compound or substance that kills microorganisms or prevents or inhibits their growth and reproduction.
- the antimicrobial agent present in the antimicrobial composition is selected to combat the microorganism(s) of concern to the degree desired.
- the antimicrobial agent is selected so as not to upset desirable physical and chemical properties of human skin.
- a properly selected antimicrobial agent maintains stability under use and storage conditions (pH, temperature, light, etc.), for a required length of time.
- a desirable property of the antimicrobial agent is that it is safe and nontoxic in handling, formulation and use, is environmentally acceptable and cost effective.
- the antimicrobial agent present in the antimicrobial composition must be capable of being solubilized in the composition without forming an association complex with other components of the composition. The formation of an association complex will prevent the antimicrobial composition from providing maximum antimicrobial efficacy.
- Classes of antimicrobial agents include, but are not limited to, phenolics, halogen compounds, quarternary ammonium compounds, metal derivatives, amines, alkanolamines and nitro derivatives, anilides, organosulfur and sulfur-nitrogen compounds.
- the antimicrobial agent is a phenol derivative.
- the phenol derivative antimicrobial agent may be selected from triclosan (2,4,4'-trichloro-2'-hydroxy diphenyl ether), triclocarban (3,4,4'-trichlorocarbanilide, phenoxyethanol, o-phenylphenol and o- phenylphenate.
- the preferred active antimicrobial agents in the antimicrobial formulation are parachlorometaxylenol (PCMX) and triclosan.
- PCMX parachlorometaxylenol
- triclosan is present in the antimicrobial formulation in an amount from about 0.5% to about 4.0%, and preferably at about 3% by weight.
- At least one surfactant is present.
- a surfactant's classification as anionic, cationic, nonionic or amphoteric depends on the charge of the surface- active moiety, usually the larger part of the molecule.
- An anionic surfactant carries a negative charge
- a cationic surfactant carries a positive charge
- a nonionic surfactant has no charge
- an amphoteric surfactant has positive and negative charges in the molecule.
- a specific selection of surfactants is required for the antimicrobial composition so that the antimicrobial agent is solubilized and an association complex is not formed between the antimicrobial agent and the surfactants.
- cationic surfactants will associate to complex an antimicrobial agent such as PCMX and therefore adversely effect the antimicrobial efficacy of the antimicrobial composition.
- the invention should not be limited to any particular theory of operation.
- nonionic, amphoteric and anionic surfactants in the antimicrobial composition will completely solubilize the antimicrobial agent such as PCMX.
- the specific combination of nonionic and anionic surfactants will also not form an association complex with the antimicrobial agent such as PCMX.
- a nonionic surfactant for the antimicrobial composition includes, but is not limited to, members of the class of block polymers that may be generically classified as poly(oxypropylene)poly-(oxyethylene) condensates whose various grades fall into a molecular weight range between 1000 to over 15,000, alkylphenol ethoxylates and primary alcohol ethoxylates.
- a series of closely related suitable block polymers for the antimicrobial composition includes, but is not limited to PLURONIC * polyols (trademark of BASF, Wyandotte Corp., Wyandotte, Michigan).
- PLURONIC polyol is a polyglycol (polyoxypropylene- polyoxyethylene block copolymer; CAS registry no.: 9003-11-6).
- Particular PLURONIC polyols that are useful include, but are not limited to: L31 , L35, F38, L43, L42, L62, L63, L64, P65, F68, L72, P75, F77, P84, P85, F87 and F88.
- a desirable PLURONIC polyol in the antimicrobial composition is L64.
- PLURONIC polyol L64 limits the formation of an association complex between the surfactants and the antimicrobial agent in the composition.
- the approximate molecular weight of PLURONIC polyol L64 is 2900.
- PLURONIC polyol L64 is present in the formulation in amount from about 1% to about 6% by weight, preferably about 2.0% by weight.
- PCMX is the preferred antimicrobial agent
- an effective amount of nonionic surfactant in the antimicrobial composition is important because the nonionic surfactant is capable of stabilizing and solubilizing PCMX in solution so as to enhance and maximize the antimicrobial activity of the antimicrobial composition. If the appropriate effective amount of nonionic surfactant is not used, the antimicrobial properties of PCMX may be weakened.
- a suitable anionic surfactant for the antimicrobial composition includes but is not limited to sulfated alkyl phenol ethoxylates and alkyl-aryl sulfonates.
- anionic surfactants may also be an aliphatic sulfonate, such as a primary alkane (C 8 -C 22 ) sulfonate, a primary alkane (C 8 -C 22 ) disulfonate, a C 8 -C 22 alkene sulfonate, C 8 -C 22 hydroxyalkane sulfonate or alkyl glyceryl ether sulfonate or an aromatic sulfonate such as alkyl benzene sulfonate.
- aliphatic sulfonate such as a primary alkane (C 8 -C 22 ) sulfonate, a primary alkane (C 8 -C 22 ) disulfonate, a C 8 -C 22 alkene sulfonate, C 8 -C 22 hydroxyalkane sulfonate or alkyl glyceryl ether sulfonate or an aromatic
- a suitable anionic surfactant for the antimicrobial composition is GAFAC* LO-529 (trademark of GAF, Wayne, NJ) sold by GAF which is a polyoxyethylene nonylphenol ether phosphate sodium salt.
- Another suitable anionic surfactant for the antimicrobial composition is WITCONATE * P-1059 (trademark of WITCO) which is an alkyl-aryl sulfonate, isopropylamine salt.
- a preferred group of anionic surfactants is the C 8 -C 18 acyl isethionates, preferably present in an amount from about 7% percent by weight to about 15% by weight, more preferably about 10% by weight.
- a preferred acyl isethionate is JORDAPON ACI- 30G, (trademark of BASF, Ludwigshafen, Germany.
- Another preferred anionic surfactant for the antimicrobial composition is an ethyl alcohol, ALIPAL * CO-436 (trademark of GAF, Wayne, NJ) sold by GAF, which is an ammonium salt of sulfated nonylphenoxypoly(ethyleneoxy)ethanol (poly(oxy-1 ,2- ethandyl.
- the ethyl alcohol anionic surfactant is present in the antimicrobial composition in an amount from about 2.0% to about 12.0% by weight and more preferably at about 6.0% by weight.
- the anionic surfactant should preferably be used in the antimicrobial composition in an amount sufficient to maintain detergent action and so as not to adversely effect the active antimicrobial properties of the antimicrobial composition.
- a combination of anionic surfactants is used, in an amount from about 7% by weight to about 22% by weight, more preferably about 16% by weight.
- Amphoteric surfactants can enhance the foaming action of the formulation.
- a desirable foam builder for the antimicrobial composition includes, but is not limited to ammonium fatty sulfo succinate, alkanolamides such as cocodieth anolamide and amine oxides such as cetyldimethyl amino oxide.
- the surfactants are sulfosuccinates and their derivatives.
- the preferred surfactants are esters of sulpho saturated and unsaturated aliphatic dicarboxylic acids such as mono and disulphosuccinic, sulphochlorosuccinic, sulphobromosuccinic, sulphoadipic, sulphopyrotartaric, sulphoglutaric, sulphosuberic, sulphosebacic, sulphobutylsuccinic, sulphobenzylsuccinic, sulphomaleic, sulphofumaric, sulphodimethylsuccinic, sulphomethylglutaric, sulphopimelinic, sulphopropylsuccinic, sulpho- octylglutaric, sulphobenzylmalonic, and other sulphonated dicarboxylic acids of the aliphatic series.
- amphoteric surfactant is an ammonium lauryl sulfosuccinate, MONAMATE * LNT-40 (a trademark of MONA Industries, Paterson, NJ) sold by MONA.
- the amphoteric surfactant is present in the antimicrobial formulation in an amount from about 2.0% to about 12.0% and most preferred at about 5.0%.
- the formulation may further include non-aqueous solvents, preferably present in an amount from about 1 % to about 8% by weight, more preferably present in an amount of about 4% by weight.
- non-aqueous solvents examples include glycols such as ethylene glycol, propylene glycol, butylene glycol, triethylene glycol, hexylene glycol, polyethylene glycols, ethoxydiglycol, and dipropyleneglycol, alcohols such as ethanol, n- propanol, and isopropanol, ethyl acetate, acetone, triacetin, and combinations thereof.
- a preferred non-aqueous solvent is propylene glycol.
- Other optional ingredients in the formulation include emollients. Emollients in general may include oils, fatty solids or waxes.
- Hydrocarbons function essentially as emollients by virtue of their ability to lubricate and/or hold water at the skin surface due to their relative occlusivity.
- Mineral oil is such a fluid.
- Some emollients are hydrophilic (glycerin, propylene glycol) and are water soluble lubricants and humectants. Since emollients may be fatty chemicals, oily or waxy in nature, they can impart barrier properties to formulations and are then referred to as moisturizers.
- Moisturizers are substances which provide external lubricant behavior, such as to soften and sooth the skin because they encourage skin water retention.
- the function of the moisturizer and/or emollient in the antimicrobial composition is to replace the natural skin oils which are lost or at least, partially removed by the cleansing action of the surfactants in the antimicrobial composition. Therefore chapping of the skin may be prevented.
- they also function to dissolve and maintain the oil-soluble antiseptics in the emulsion.
- Suitable moisturizes and/or emollients in the antimicrobial composition include, but are not limited to fatty acids, thglycerides, lanolin, derivatives of lanolin such as the ethoxylated, acetylated alcohol and surface active alcohol derivatives of lanolin, propylene glycol, polypropylene glycol, polyethylene glycol, lanolin and lanolin derivatives, mineral oils, fatty alcohols and glycerine.
- a preferable moisturizer and/or emollient for the antimicrobial composition is an ethoxylated (75 moles) lanolin, SOLULAN * 75 (trademark of Amerchol Corporation, Edison, NJ) sold by Amerchol Corporation.
- Another preferred moisturizer and/or emollient for the antimicrobial composition is an aloe vera or an ester comprising isopropyl palmitate and lanolin oil, ISOPROPYLAN* 50 (trademark of Amerchol Corporation, Edison, NJ) sold by Amerchol Corporation.
- moisturizer and/or emollient for the antimicrobial composition is a polyethyl glycol lanolin derivative, PEG * 75 lanolin (trademark of Amerchol Corporation, Edison, N.J.) sold by Amerchol Corporation.
- PEG * 75 lanolin trademark of Amerchol Corporation, Edison, N.J.
- Another preferred emollient is aloe vera gel.
- a combination of moisturizers and/or emollients is present in the antimicrobial formulation in an amount from about 1.0% to about 5.0% by weight and most preferred at about 2.6%.
- the antimicrobial formulation may further include fragrance and colorants in amounts of less than about 2.0% by weight.
- the balance of the antimicrobial composition is preferably water.
- the water may be present in the antimicrobial composition in an amount from about 60.0% to about 85.0%.
- the antimicrobial composition of the invention may include a perfume to provide a pleasing scent or a dye to provide a characteristic color.
- a preferred formulation of the present invention comprises: a. about 0.5% to about 4% by weight of para-chlorometa-xylenol or triclosan;
- the antimicrobial compositions of the present invention may be found to be highly effective against common microorganisms such as Staphylococcus aureus. Pseudomonas aeruqinosa. Candida albicans and Escherichia coli. among others as well as. It is recognized, however, that the effectiveness of the antimicrobial composition depends upon the particular combination of materials, the concentration of ingredients used and the nature of the particular microorganism.
- the general procedure for combining the ingredients utilized conventional techniques.
- the lanolin derivative was preheated in a heated tank overnight until the material was melted and in a liquid state.
- the polyoxypropylene polyoxyethylene block copolymer, ALIPAL CO-436, propylene glycol and ammonium lauryl sulfosuccinate were mixed in a mixing tank.
- PCMX for Examples 1 to 5
- Triclosan for Examples 6-7
- the lanolin derivative was added from the heated tank, and then the ammonium cocoyl isethionate was added. Next, purified water was added, and finally, the colorants, aloe vera gel and fragrance were added to the formulation. Samples were measured for pH, and the pH was adjusted to between 7-8 by adding sodium hydroxide or hydrochloric acid.
- Example 5 (designated as A in Table II) and Example 7 (designated as B in Table II were tested and compared with the commercially available Ultradex® product, which contains 3% PCMX and is described in United States patent number 4,632,772 issued to Garabedian et. al, to determine their antimicrobial efficacy.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
An antimicrobial formulation which comprises an antimicrobial agent, a surfactant and an emollient. The formulation has a low viscosity and has excellent foaming properties when used in a foaming dispenser. The formulation is useful in providing antimicrobial effectiveness in surgical scrub applications.
Description
FOAMABLE ANTIMICROBIAL FORMULATION BACKGROUND
This invention relates to antimicrobial formulations. More particularly, the invention relates to formulations that may be utilized in dispensing devices that generate a foam. Such formulations are particularly useful in the health care profession such as in surgical practice as a pre-operative scrub. Hand washing by healthcare professionals is an essential component of infection control activities. Healthcare professionals wash their hands regularly to control the spread of infection from patient to patient. Hand washing procedures are performed in several ways and include products such as ordinary antimicrobial bar soaps, skin disinfecting or pre-operative prepping agents or rubbing alcohol. Such procedures and products may contain antimicrobial agents such as iodine, chlorhexidine gluconate, para-chlorometa-xylenol and hexachlorophenes.
Historically, the healthcare industry has used scrub brushes impregnated with antimicrobial agents for surgical skin preparation and pre and post patient care. These impregnated scrub brushes have proven to be an effective method of reducing the spread of infection in the healthcare setting and use a solution specifically designed for use in the scrub brush where the mechanical action of scrubbing with the foam brush creates a foam or lather.
In a continued effort to reduce the amount of cross contamination and to make these antimicrobial agents more accessible to a larger number of healthcare professionals and patients, the healthcare industry has more recently turned to bulk antimicrobial solution dispensing systems. These bulk systems have generally used solutions designed to be dispensed as liquid soap. Some solution dispensing systems provide a means for foaming the antimicrobial solution so that the solution is dispensed in a foamed state. An example of a foam solution dispensing system is described in copending United States patent application serial number 09/512,402, entitled, "Foam Forming Liquid Dispensing Device."
The foam generating device and system disclosed in United States application serial number 09/512,402 dispenses a homogeneous foam solution when the proper mixing of foamable solution and air occurs. The system includes a pressure generating source, such as a foot pump, which creates an increased pressure inside the closed container. This positive pressure difference across the container wall results in the solution being forced up the solution delivery straw. This increased pressure also forces air into the solution delivery straw via the air delivery cross tube located above the level of the foamable solution. The air/solution mixture is then allowed to expand downstream of the air delivery cross tube prior to be forced through a flow restricter, which further homogenizes the air/solution mixture.
Typically the solutions used in dispensing devices are high viscosity, which require higher pressure to force the solution up the solution delivery straw. The increased pressure needed to deliver the solution tends to deliver too much air into the system, which can cause in an improper ratio of solution to air, and ultimately a poorly foamed
solution. Higher viscosity solutions also do not expand and mix as readily when being forced around and through the flow restricters in the dispensing devices. For example, the solution described in United States patent number 5,439,681 , which has a viscosity in the range of 490 to 500 centipoise at 24° C, is difficult to deliver through foaming dispenser devices that include flow restricters.
A low viscosity, highly foamable solution is therefore needed to provide the desirable foam output characteristics while maintaining other desirable characteristics. Accordingly, it would be desirable to provide an antimicrobial formulation having a low viscosity, which is highly foamable when used in a foam dispensing device. Additionally, it would be advantageous if the foam produced from the solution is homogenous, consisting of small, homogenous bubbles, having consistency that is neither too wet nor too dry. It would also be desirable it the foam could be smoothly delivered at a consistent volume through the delivery device.
SUMMARY OF THE INVENTION The present invention is an aqueous foamable antimicrobial formulation comprising an antimicrobial agent, surfactants and emollients. The formulation may be effectively used as a surgical scrub without irritation or dryness to skin.
The aqueous foamable, antimicrobial cleansing formulation of the present invention comprises about 1 % to about 4% of an antimicrobial agent having a phenol moeity, about 18% to about
surfactants, anionic surfactants, amphoteric surfactants, and mixtures thereof; and about 1 % to about 5% of an emollient. Preferably, formulation has a viscosity less than 300 centipoise at 24° C, and the viscosity is more preferably less than 200 centipoise at 24° C. In a most preferred embodiment, the formulation has a viscosity less than 100 centipoise at 24° C, typically in the range of about 5 centipoise to about 30 centipoise at 24° C.
In a preferred embodiment, the antimicrobial agent used in the formulation includes triclosan or para-chlorometa-xylenol. Preferably, the surfactant used in the formulation includes an ammonium salt of sulfated nonylphenoxypolyethyloxyethanol, block copolymers of polyoxyethylene and polyoxypropylene, ammonium fatty sulfosuccinates, acyl isethionates and combinations thereof. In a preferred formulation the emollient is selected from lanolin, lanolin derivatives and aloe vera gel, and the formulation includes a glycol such as propylene glycol.
In a most preferred embodiment of the present invention, the formulation comprises about 0.5% to about 4% para- chlorometa-xylenol or triclosan; about 5-20% ammonium cocoyl isethionate; about 1 % to about 7% block copolymers of polyoxypropylene and polyoxyethylene; about 3% to about 12% nonylphenoxypolyethylenoxy propanol; and about 2% to about 10% ammonium lauryl sulfosuccinate. The percentages are all in weight percent. The present invention provides an aqueous antimicrobial formulation that has lower viscosity than prior art antimicrobial formulations. The lower viscosity formulation of the present
invention permits antimicrobial dispensing devices such as the device described in United States patent application serial number 09/512,402 to dispense a foam having small, homogenous bubbles at a consistent delivery volume. Advantageously, the solution provides consistent foam delivery when dispensed from such a dispensing device. The foam produced by the dispensing device has acceptable foam density and is delivered smoothly from the dispensing device. These and other advantages will become apparent from the following detailed description.
DETAILED DESCRIPTION
The present invention relates to aqueous foamable, antimicrobial formulations. One important feature of the formulations of the present invention is the formulations possess a viscosity less than about 300 centipoise at 24° C, preferably less than about 200 centipoise at 24° C, and most preferably less than about 100 centipoise at 24° C. It will be appreciated that the measured viscosity of the formulation will increase as the temperature of the formulation is lowered. The low viscosity solution of the present invention is particularly useful in foam generating dispensing devices, such as the type disclosed in copending United States patent application serial number 09/ 512,402.
The aqueous, antimicrobial formulation of the present invention generally comprises about 0.5% to about 4% by weight of an antimicrobial agent having a phenol moeity, about 18% to about 35% by weight of a surfactant selected from the group consisting of
nonionic surfactants, anionic surfactants, amphoteric surfactants, and mixtures thereof, and about 1 % to about 5% by weight of an emollient. Each component is described further below.
An antimicrobial agent is a compound or substance that kills microorganisms or prevents or inhibits their growth and reproduction. The antimicrobial agent present in the antimicrobial composition is selected to combat the microorganism(s) of concern to the degree desired. The antimicrobial agent is selected so as not to upset desirable physical and chemical properties of human skin. A properly selected antimicrobial agent maintains stability under use and storage conditions (pH, temperature, light, etc.), for a required length of time. A desirable property of the antimicrobial agent is that it is safe and nontoxic in handling, formulation and use, is environmentally acceptable and cost effective. The antimicrobial agent present in the antimicrobial composition must be capable of being solubilized in the composition without forming an association complex with other components of the composition. The formation of an association complex will prevent the antimicrobial composition from providing maximum antimicrobial efficacy.
Classes of antimicrobial agents include, but are not limited to, phenolics, halogen compounds, quarternary ammonium compounds, metal derivatives, amines, alkanolamines and nitro derivatives, anilides, organosulfur and sulfur-nitrogen compounds. Preferably, the antimicrobial agent is a phenol derivative.
The phenol derivative antimicrobial agent may be selected from triclosan (2,4,4'-trichloro-2'-hydroxy diphenyl ether), triclocarban
(3,4,4'-trichlorocarbanilide, phenoxyethanol, o-phenylphenol and o- phenylphenate. The preferred active antimicrobial agents in the antimicrobial formulation are parachlorometaxylenol (PCMX) and triclosan. Preferably, the PCMX or triclosan is present in the antimicrobial formulation in an amount from about 0.5% to about 4.0%, and preferably at about 3% by weight.
According to the present invention, at least one surfactant is present. A surfactant's classification as anionic, cationic, nonionic or amphoteric, depends on the charge of the surface- active moiety, usually the larger part of the molecule. An anionic surfactant carries a negative charge, a cationic surfactant carries a positive charge, a nonionic surfactant has no charge and an amphoteric surfactant has positive and negative charges in the molecule. A specific selection of surfactants is required for the antimicrobial composition so that the antimicrobial agent is solubilized and an association complex is not formed between the antimicrobial agent and the surfactants. In particular, it is believed that cationic surfactants will associate to complex an antimicrobial agent such as PCMX and therefore adversely effect the antimicrobial efficacy of the antimicrobial composition. However, the invention should not be limited to any particular theory of operation.
It is believed that a combination of specific nonionic, amphoteric and anionic surfactants in the antimicrobial composition will completely solubilize the antimicrobial agent such as PCMX. The specific combination of nonionic and anionic surfactants will
also not form an association complex with the antimicrobial agent such as PCMX.
A nonionic surfactant for the antimicrobial composition includes, but is not limited to, members of the class of block polymers that may be generically classified as poly(oxypropylene)poly-(oxyethylene) condensates whose various grades fall into a molecular weight range between 1000 to over 15,000, alkylphenol ethoxylates and primary alcohol ethoxylates.
A series of closely related suitable block polymers for the antimicrobial composition includes, but is not limited to PLURONIC* polyols (trademark of BASF, Wyandotte Corp., Wyandotte, Michigan). PLURONIC polyol is a polyglycol (polyoxypropylene- polyoxyethylene block copolymer; CAS registry no.: 9003-11-6). Particular PLURONIC polyols that are useful include, but are not limited to: L31 , L35, F38, L43, L42, L62, L63, L64, P65, F68, L72, P75, F77, P84, P85, F87 and F88.
A desirable PLURONIC polyol in the antimicrobial composition is L64. PLURONIC polyol L64 limits the formation of an association complex between the surfactants and the antimicrobial agent in the composition. The approximate molecular weight of PLURONIC polyol L64 is 2900. Preferably, PLURONIC polyol L64 is present in the formulation in amount from about 1% to about 6% by weight, preferably about 2.0% by weight.
In embodiments in which PCMX is the preferred antimicrobial agent, it is believed that an effective amount of nonionic surfactant in the antimicrobial composition is important because the nonionic surfactant is capable of stabilizing and
solubilizing PCMX in solution so as to enhance and maximize the antimicrobial activity of the antimicrobial composition. If the appropriate effective amount of nonionic surfactant is not used, the antimicrobial properties of PCMX may be weakened. A suitable anionic surfactant for the antimicrobial composition includes but is not limited to sulfated alkyl phenol ethoxylates and alkyl-aryl sulfonates. It is believed that only specific suitable anionic surfactants may be used with specific nonionic surfactants so as to enhance and maximize the antimicrobial activity of the antimicrobial agent, such as PCMX. The anionic surfactants may also be an aliphatic sulfonate, such as a primary alkane (C8-C22) sulfonate, a primary alkane (C8-C22) disulfonate, a C8-C22 alkene sulfonate, C8-C22 hydroxyalkane sulfonate or alkyl glyceryl ether sulfonate or an aromatic sulfonate such as alkyl benzene sulfonate.
A suitable anionic surfactant for the antimicrobial composition is GAFAC* LO-529 (trademark of GAF, Wayne, NJ) sold by GAF which is a polyoxyethylene nonylphenol ether phosphate sodium salt. Another suitable anionic surfactant for the antimicrobial composition is WITCONATE* P-1059 (trademark of WITCO) which is an alkyl-aryl sulfonate, isopropylamine salt.
A preferred group of anionic surfactants is the C8-C18 acyl isethionates, preferably present in an amount from about 7% percent by weight to about 15% by weight, more preferably about 10% by weight. A preferred acyl isethionate is JORDAPON ACI- 30G, (trademark of BASF, Ludwigshafen, Germany.
Another preferred anionic surfactant for the antimicrobial composition is an ethyl alcohol, ALIPAL* CO-436 (trademark of GAF, Wayne, NJ) sold by GAF, which is an ammonium salt of sulfated nonylphenoxypoly(ethyleneoxy)ethanol (poly(oxy-1 ,2- ethandyl. Preferably, the ethyl alcohol anionic surfactant is present in the antimicrobial composition in an amount from about 2.0% to about 12.0% by weight and more preferably at about 6.0% by weight. The anionic surfactant should preferably be used in the antimicrobial composition in an amount sufficient to maintain detergent action and so as not to adversely effect the active antimicrobial properties of the antimicrobial composition. In particular, it is not desirable for the anionic surfactant to complex with the antimicrobial agent. Preferably, a combination of anionic surfactants is used, in an amount from about 7% by weight to about 22% by weight, more preferably about 16% by weight.
Amphoteric surfactants can enhance the foaming action of the formulation. A desirable foam builder for the antimicrobial composition includes, but is not limited to ammonium fatty sulfo succinate, alkanolamides such as cocodieth anolamide and amine oxides such as cetyldimethyl amino oxide. In the preferred embodiment, the surfactants are sulfosuccinates and their derivatives. The preferred surfactants are esters of sulpho saturated and unsaturated aliphatic dicarboxylic acids such as mono and disulphosuccinic, sulphochlorosuccinic, sulphobromosuccinic, sulphoadipic, sulphopyrotartaric, sulphoglutaric, sulphosuberic, sulphosebacic, sulphobutylsuccinic, sulphobenzylsuccinic, sulphomaleic, sulphofumaric, sulphodimethylsuccinic, sulphomethylglutaric, sulphopimelinic, sulphopropylsuccinic, sulpho-
octylglutaric, sulphobenzylmalonic, and other sulphonated dicarboxylic acids of the aliphatic series.
Currently, the most preferred commercially available amphoteric surfactant is an ammonium lauryl sulfosuccinate, MONAMATE* LNT-40 (a trademark of MONA Industries, Paterson, NJ) sold by MONA. Preferably, the amphoteric surfactant is present in the antimicrobial formulation in an amount from about 2.0% to about 12.0% and most preferred at about 5.0%. The formulation may further include non-aqueous solvents, preferably present in an amount from about 1 % to about 8% by weight, more preferably present in an amount of about 4% by weight. Examples of suitable non-aqueous solvents include glycols such as ethylene glycol, propylene glycol, butylene glycol, triethylene glycol, hexylene glycol, polyethylene glycols, ethoxydiglycol, and dipropyleneglycol, alcohols such as ethanol, n- propanol, and isopropanol, ethyl acetate, acetone, triacetin, and combinations thereof. A preferred non-aqueous solvent is propylene glycol. Other optional ingredients in the formulation include emollients. Emollients in general may include oils, fatty solids or waxes. Hydrocarbons function essentially as emollients by virtue of their ability to lubricate and/or hold water at the skin surface due to their relative occlusivity. Mineral oil is such a fluid. Some emollients are hydrophilic (glycerin, propylene glycol) and are water soluble lubricants and humectants. Since emollients may be fatty
chemicals, oily or waxy in nature, they can impart barrier properties to formulations and are then referred to as moisturizers.
Moisturizers are substances which provide external lubricant behavior, such as to soften and sooth the skin because they encourage skin water retention. The function of the moisturizer and/or emollient in the antimicrobial composition is to replace the natural skin oils which are lost or at least, partially removed by the cleansing action of the surfactants in the antimicrobial composition. Therefore chapping of the skin may be prevented. In addition, they also function to dissolve and maintain the oil-soluble antiseptics in the emulsion.
Suitable moisturizes and/or emollients in the antimicrobial composition include, but are not limited to fatty acids, thglycerides, lanolin, derivatives of lanolin such as the ethoxylated, acetylated alcohol and surface active alcohol derivatives of lanolin, propylene glycol, polypropylene glycol, polyethylene glycol, lanolin and lanolin derivatives, mineral oils, fatty alcohols and glycerine.
A preferable moisturizer and/or emollient for the antimicrobial composition is an ethoxylated (75 moles) lanolin, SOLULAN*75 (trademark of Amerchol Corporation, Edison, NJ) sold by Amerchol Corporation. Another preferred moisturizer and/or emollient for the antimicrobial composition is an aloe vera or an ester comprising isopropyl palmitate and lanolin oil, ISOPROPYLAN* 50 (trademark of Amerchol Corporation, Edison, NJ) sold by Amerchol Corporation. Another preferred moisturizer and/or emollient for the antimicrobial composition is a polyethyl glycol lanolin derivative, PEG*75 lanolin (trademark of Amerchol
Corporation, Edison, N.J.) sold by Amerchol Corporation. Another preferred emollient is aloe vera gel.
Preferably, a combination of moisturizers and/or emollients is present in the antimicrobial formulation in an amount from about 1.0% to about 5.0% by weight and most preferred at about 2.6%.
The antimicrobial formulation may further include fragrance and colorants in amounts of less than about 2.0% by weight.
The balance of the antimicrobial composition is preferably water. The water may be present in the antimicrobial composition in an amount from about 60.0% to about 85.0%.
Other ingredients which are conventional or desirable in various cosmetic formulations may also be added to the antimicrobial composition as long as they do not adversely affect the overall properties of the antimicrobial composition. If desired, the antimicrobial composition of the invention may include a perfume to provide a pleasing scent or a dye to provide a characteristic color.
A preferred formulation of the present invention comprises: a. about 0.5% to about 4% by weight of para-chlorometa-xylenol or triclosan;
b. about 5 to about 20% by weight of ammonium cocoyl isethionate;
c. about 1 % to about 7% by weight of block copolymers of polyoxypropylene and polyoxyethylene;
d. about 3% to about 12% by weight of nonylphenoxypolyethylenoxy propanol; and
about 2% to about 10% by weight of ammonium lauryl sulfosuccinate.
The antimicrobial compositions of the present invention may be found to be highly effective against common microorganisms such as Staphylococcus aureus. Pseudomonas aeruqinosa. Candida albicans and Escherichia coli. among others as well as. It is recognized, however, that the effectiveness of the antimicrobial composition depends upon the particular combination of materials, the concentration of ingredients used and the nature of the particular microorganism.
The present invention is set forth in greater detail in the examples which follow. The examples are for illustration purposes only and are not intended to limit the scope of the claims in any way. Generally, the ingredients are identified by their chemical name, CFTA name, or by their trade names. All percentages are in weight percent, and the balance of each example is comprised of water.
EXAMPLES
FORMULATION OF ANTIMICROBIAL COMPOSITIONS
TABLE I
The general procedure for combining the ingredients utilized conventional techniques. The lanolin derivative was preheated in a heated tank overnight until the material was melted and in a liquid state. The polyoxypropylene polyoxyethylene block copolymer, ALIPAL CO-436, propylene glycol and ammonium lauryl sulfosuccinate were mixed in a
mixing tank. PCMX (for Examples 1 to 5) or Triclosan (for Examples 6-7) was added next until dissolved. The lanolin derivative was added from the heated tank, and then the ammonium cocoyl isethionate was added. Next, purified water was added, and finally, the colorants, aloe vera gel and fragrance were added to the formulation. Samples were measured for pH, and the pH was adjusted to between 7-8 by adding sodium hydroxide or hydrochloric acid.
Antimicrobial Activity
Example 5 (designated as A in Table II) and Example 7 (designated as B in Table II were tested and compared with the commercially available Ultradex® product, which contains 3% PCMX and is described in United States patent number 4,632,772 issued to Garabedian et. al, to determine their antimicrobial efficacy.
Full strength formulations of A, B and C were diluted with water at a ratio of 1 :10 and 1 :100. The full strength solutions and the diluted samples were each challenged with 0.1 m. of innoculum containing the number of colony forming units (CFU) of the organisms listed in Table II. The results reported in Table II show the kill time in minutes. "Positive" means colonies were observed after exposure and neutralization (i.e. total kill not achieved). The kill time of 1 minute or 5 minutes means that total kill was achieved after the respective exposure time.
Table II
Since Staphylococcus aureus is the most commonly found organisms on skin and often difficult to kill completely, the formulations and B of the present invention are more effective than the formulation C disclosed in United States patent number 4,632,772. The present invention may be embodied in other specific forms and is not limited to any specific embodiments described in detail which are merely exemplary. Various other modifications will be apparent to and readily made by those skilled in the art without departing from the scope and spirit of the invention. The scope of the invention will be measured by the appended claims and their equivalents.
Claims
1. An aqueous foamable, antimicrobial liquid cleansing formulation comprising: about 0.5% to about 4% by weight of an antimicrobial agent having a phenol moeity, about 18% to about 35% by weight of a surfactant selected from the group consisting of nonionic surfactants, anionic surfactants, amphoteric surfactants, and mixtures thereof; and about 1 % to about 5% by weight of an emollient.
2. The formulation of claim 1 , wherein the formulation has a viscosity less than 300 centipoise at 24° C.
3. The formulation of claim 1 , wherein the formulation has a viscosity less than less than 200 centipoise at 24° C.
4. The formulation of claim 1 , wherein the formulation has a viscosity less than 100 centipoise at 24° C.
5. The formulation of claim 4, wherein the antimicrobial agent includes triclosan or para-chlorometa-xylenol.
6. The formulation of claim 5, wherein the surfactant includes an ammonium salt of sulfated nonylphenoxypolyethyloxyethanol, block copolymers of polyoxyethylene and polyoxypropylene, ammonium fatty sulfosuccinates, acyl isethionates and combinations thereof.
7. The formulation of claim 6, wherein the emollient is selected from lanolin, lanolin derivatives and aloe vera gel.
8. The formulation of claim 7, wherein further comprising a glycol.
9. A foamable, antimicrobial liquid cleansing formulation comprising: an antimicrobial agent selected from the group consisting of triclosan and para-chlorometa-xylenol; an ammonium salt of sulfated nonylphenoxypolyethylenoxy ethanol; ammonium lauryl sulfosuccinate; and
ammonium cocoyl isethionate.
10. The formulation of claim 9, wherein the formulation has a viscosity of less than 200 centipoise at 24° C.
11. The formulation of claim 9, wherein the formulation has a viscosity less than 100 centipoise at 24° C.
12. The formulation of claim 9, further comprising lanolin and propylene glycol.
13. A foamable, antimicrobial liquid cleansing formulation comprising:
a. about 0.5% to about 4% by weight of para-chlorometa- xylenol or triclosan;
e. about 5 to about 20% by weight of ammonium cocoyl isethionate;
f. about 1% to about 7% by weight of block copolymers of polyoxypropylene and polyoxyethylene;
g. about 3% to about 12% by weight of nonylphenoxypolyethylenoxy propanol; and
h. about 2% to about 10% by weight of ammonium lauryl sulfosuccinate.
14. The formulation of claim 13, further comprising one or more of the group including glycols, triglycerides, and alcohols.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001249365A AU2001249365A1 (en) | 2000-04-04 | 2001-03-22 | Foamable antimicrobial formulation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54289600A | 2000-04-04 | 2000-04-04 | |
US09/542,896 | 2000-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001074983A1 true WO2001074983A1 (en) | 2001-10-11 |
Family
ID=24165745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/009267 WO2001074983A1 (en) | 2000-04-04 | 2001-03-22 | Foamable antimicrobial formulation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001249365A1 (en) |
WO (1) | WO2001074983A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003044144A1 (en) * | 2001-11-16 | 2003-05-30 | Becton, Dickinson And Company | Foamable antimicrobial formulation |
WO2009050447A3 (en) * | 2007-10-19 | 2009-08-27 | Magenta Trading Limited | Water-based skin products |
EP1638516B1 (en) * | 2003-07-01 | 2010-03-10 | SkinSure International Limited | Barrier formulation comprising a silicone based emulsion |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0086878A1 (en) * | 1982-02-22 | 1983-08-31 | Dexide, Inc. | Mild antimicrobial detergent composition |
WO1991017237A1 (en) * | 1990-04-27 | 1991-11-14 | The Procter & Gamble Company | Cleansing products |
US5439681A (en) * | 1991-03-25 | 1995-08-08 | Becton Dickinson And Company | Parachlorometaxylenol antimicrobial formulation |
EP0689767A2 (en) * | 1994-06-27 | 1996-01-03 | Becton, Dickinson and Company | Skin disinfecting formulations |
WO1996006153A2 (en) * | 1994-08-25 | 1996-02-29 | Ciba Specialty Chemicals Holding Inc. | Surface-active formulations |
EP0882446A1 (en) * | 1997-06-02 | 1998-12-09 | Gojo Industries,Inc. | Antimicrobial skin cleansing compositions |
-
2001
- 2001-03-22 WO PCT/US2001/009267 patent/WO2001074983A1/en active Application Filing
- 2001-03-22 AU AU2001249365A patent/AU2001249365A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0086878A1 (en) * | 1982-02-22 | 1983-08-31 | Dexide, Inc. | Mild antimicrobial detergent composition |
WO1991017237A1 (en) * | 1990-04-27 | 1991-11-14 | The Procter & Gamble Company | Cleansing products |
US5439681A (en) * | 1991-03-25 | 1995-08-08 | Becton Dickinson And Company | Parachlorometaxylenol antimicrobial formulation |
EP0689767A2 (en) * | 1994-06-27 | 1996-01-03 | Becton, Dickinson and Company | Skin disinfecting formulations |
WO1996006153A2 (en) * | 1994-08-25 | 1996-02-29 | Ciba Specialty Chemicals Holding Inc. | Surface-active formulations |
EP0882446A1 (en) * | 1997-06-02 | 1998-12-09 | Gojo Industries,Inc. | Antimicrobial skin cleansing compositions |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003044144A1 (en) * | 2001-11-16 | 2003-05-30 | Becton, Dickinson And Company | Foamable antimicrobial formulation |
EP1638516B1 (en) * | 2003-07-01 | 2010-03-10 | SkinSure International Limited | Barrier formulation comprising a silicone based emulsion |
WO2009050447A3 (en) * | 2007-10-19 | 2009-08-27 | Magenta Trading Limited | Water-based skin products |
Also Published As
Publication number | Publication date |
---|---|
AU2001249365A1 (en) | 2001-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5439681A (en) | Parachlorometaxylenol antimicrobial formulation | |
EP0689767B1 (en) | Skin disinfecting formulations | |
JP3889812B2 (en) | Antibacterial composition and wet wipes containing the same | |
US5607699A (en) | Non-aqueous emiollient iodophor formulations | |
US20210046142A1 (en) | Hand sanitizer composition and method of manufacture | |
PT89126B (en) | A process for the preparation of a soft cleansing and conditioning composition for skin lotion comprising low levels of a nonionic active agent and an organic acid | |
US11576880B2 (en) | Feminine hygiene products | |
US20230093881A1 (en) | Hand sanitizer and method of making the same | |
US20020123440A1 (en) | Foamable antimicrobial formulation | |
US20100136079A1 (en) | Antiseptic wipes | |
US8357392B2 (en) | Dry antiseptic wipes comprising an amphoteric surfactant | |
WO2001074983A1 (en) | Foamable antimicrobial formulation | |
JP2023146622A (en) | Method for producing liquid disinfectant composition | |
CN116472022A (en) | Stable antimicrobial agent concentrate | |
MXPA99011307A (en) | Mild, rinse-off antimicrobial liquid cleansing compositions | |
MXPA98003337A (en) | Methods to incorporate a hydrophobic substance in an acu solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |